http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-006639-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_634715a790f7ef0163a61e9f364bebcd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B57-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
filingDate 1997-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1999-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-006639-A1
titleOfInvention IMPROVED PROCEDURE FOR THE PRODUCTION OF ENANTIOMERICALLY PURE AZETIDINE-2-CARBOXYLIC ACID
abstract A process for the production of enantiomerically pure azetidine-2-carboxylic acid comprising the selective crystallization of an enantiomerically pure acid salt from a homogeneous solution of azetidine-2-carboxylic acid, optically active tartaric acid, an organic acid and an aldehyde followed by the release of the free amino acid. It also refers to a process for the conversion of the enantiomer of the aforementioned acid from the form Da to form L- and vice versa by selective crystallization of a D-L-acid tartrate salt (or D-acid L-tartrate) diastereomerically pure from a homogeneous solution of D-acid respectively of L-acid) azetidine-2-carboxylic acid, tartaric acid, an organic acid and an alcohol followed by release of the free amino acid. Said organic acid can be used as a solvent; and said aldehyde can be butyric or caproic. Selective crystallization is achieved through a temperature in the range between -10 and 30 * C.
priorityDate 1996-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532039

Total number of triples: 23.